Access cutting-edge bipolar disorder treatment through this clinical trial at a research site in Riverside. Study-provided care at no cost to qualified participants.
Access bipolar disorder specialists in Riverside at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bipolar disorder treatment provided free
This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episode of mania or mania with mixed features. The primary objective of the study is to evaluate the efficacy of KarXT compared to placebo in treating symptoms of mania during a 3-week inpatient period. The duration of the study including screening, the double-blind inpatient treatment period and safety-follow-up is no more than seven weeks.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this bipolar disorder clinical trial in Riverside, CA
If you're searching for bipolar disorder treatment options in Riverside, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Riverside research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bipolar disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.